Novel quinolinonyl diketo acids were designed to obtain integrase (IN) inhibitors selectively active against the strand transfer (ST) step of the HIV integration process. Those new compounds are characterized by a single aryl diketo acid (DKA) chain in comparison to 4, a bifunctional diketo acid reported by our group as an anti-IN agent highly potent against both the 3'-processing and ST steps. Compound 6d was the most potent derivative in IN enzyme assays, while 6i showed the highest potency against HIV-1 in acutely infected cells. The selective inhibition of ST suggested the newly designed monofunctional DKAs bind the IN-DNA acceptor site without affecting the DNA donor site.

Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: Design, synthesis, and biological activities / DI SANTO, Roberto; Costi, Roberta; Alessandra, Roux; Gaetano, Miele; Giuliana Cuzzucoli, Crucitti; Alberto, Iacovo; Federica, Rosi; Antonio, Lavecchia; Luciana, Marinelli; Carmen Di, Giovanni; Ettore, Novellino; Lucia, Palmisano; M., Andreaotti; Roberta, Amici; Clementina Maria, Galluzzo; Nencioni, Lucia; Palamara, ANNA TERESA; Yves, Pommier; Christophe, Marchand. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 51:15(2008), pp. 4744-4750. [10.1021/jm8001422]

Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: Design, synthesis, and biological activities

DI SANTO, Roberto;COSTI, Roberta;NENCIONI, Lucia;PALAMARA, ANNA TERESA;
2008

Abstract

Novel quinolinonyl diketo acids were designed to obtain integrase (IN) inhibitors selectively active against the strand transfer (ST) step of the HIV integration process. Those new compounds are characterized by a single aryl diketo acid (DKA) chain in comparison to 4, a bifunctional diketo acid reported by our group as an anti-IN agent highly potent against both the 3'-processing and ST steps. Compound 6d was the most potent derivative in IN enzyme assays, while 6i showed the highest potency against HIV-1 in acutely infected cells. The selective inhibition of ST suggested the newly designed monofunctional DKAs bind the IN-DNA acceptor site without affecting the DNA donor site.
2008
01 Pubblicazione su rivista::01a Articolo in rivista
Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: Design, synthesis, and biological activities / DI SANTO, Roberto; Costi, Roberta; Alessandra, Roux; Gaetano, Miele; Giuliana Cuzzucoli, Crucitti; Alberto, Iacovo; Federica, Rosi; Antonio, Lavecchia; Luciana, Marinelli; Carmen Di, Giovanni; Ettore, Novellino; Lucia, Palmisano; M., Andreaotti; Roberta, Amici; Clementina Maria, Galluzzo; Nencioni, Lucia; Palamara, ANNA TERESA; Yves, Pommier; Christophe, Marchand. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 51:15(2008), pp. 4744-4750. [10.1021/jm8001422]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/359251
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 47
social impact